ArticleAmerican journal of hematology2021

A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.

Melissa Alsina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.